 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Prevention/Epidemiology Gen-Probe Test Receives FDA ApprovalAugust 11, 2005 On Wednesday, Gen-Probe Inc. announced that the Food and Drug Administration has approved its Aptima Combo 2 test to detect chlamydia and gonorrhea using liquid Pap specimens processed by Cytyc Corp's ThinPrep 2000 system. Gen-Probe said agency permission to use the two systems together will make its product more comprehensive and more convenient for physicians to administer and will lower costs. Cytyc's ThinPrep is the most commonly used cervical cancer test in the United States; Aptima Combo 2 simultaneously detects both STDs. Associated Press 08.10.2005  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
